197 related articles for article (PubMed ID: 1629715)
1. N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.
Maruyama W; Nakahara D; Ota M; Takahashi T; Takahashi A; Nagatsu T; Naoi M
J Neurochem; 1992 Aug; 59(2):395-400. PubMed ID: 1629715
[TBL] [Abstract][Full Text] [Related]
2. A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain.
Maruyama W; Sobue G; Matsubara K; Hashizume Y; Dostert P; Naoi M
Neurosci Lett; 1997 Feb; 223(1):61-4. PubMed ID: 9058423
[TBL] [Abstract][Full Text] [Related]
3. N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
Naoi M; Dostert P; Yoshida M; Nagatsu T
Adv Neurol; 1993; 60():212-7. PubMed ID: 8420137
[TBL] [Abstract][Full Text] [Related]
4. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
Naoi M; Maruyama W; Nagy GM
Neurotoxicology; 2004 Jan; 25(1-2):193-204. PubMed ID: 14697894
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.
Naoi M; Maruyama W; Kasamatsu T; Dostert P
J Neural Transm Suppl; 1998; 52():125-38. PubMed ID: 9564615
[TBL] [Abstract][Full Text] [Related]
6. Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: in vivo and in vitro studies.
Maruyama W; Dostert P; Naoi M
J Neurochem; 1995 Jun; 64(6):2635-43. PubMed ID: 7760044
[TBL] [Abstract][Full Text] [Related]
7. Endogenous synthesis of N-methylsalsolinol, an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in rat brain during in vivo microdialysis with salsolinol, as demonstrated by gas chromatography-mass spectrometry.
Niwa T; Maruyama W; Nakahara D; Takeda N; Yoshizumi H; Tatematsu A; Takahashi A; Dostert P; Naoi M; Nagatsu T
J Chromatogr; 1992 Jul; 578(1):109-15. PubMed ID: 1400775
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain.
Antkiewicz-Michaluk L; Romañska I; Papla I; Michaluk J; Bakalarz M; Vetulani J; Krygowska-Wajs A; Szczudlik A
Neuroscience; 2000; 96(1):59-64. PubMed ID: 10683410
[TBL] [Abstract][Full Text] [Related]
9. N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.
Naoi M; Maruyama W; Dostert P; Hashizume Y
J Neural Transm Suppl; 1997; 50():89-105. PubMed ID: 9120428
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the in vivo action of (R)-salsolinol, an endogenous metabolite of alcohol, on serotonin and dopamine metabolism: a microdialysis study.
Nakahara D; Maruyama W; Hashiguti H; Naoi M
Brain Res; 1994 May; 644(2):226-32. PubMed ID: 8050034
[TBL] [Abstract][Full Text] [Related]
11. A systematic regional study of dopamine and dopamine-derived salsolinol and norsalsolinol levels in human brain areas.
Musshoff F; Schmidt P; Dettmeyer R; Priemer F; Wittig H; Madea B
Forensic Sci Int; 1999 Oct; 105(1):1-11. PubMed ID: 10605071
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons.
Naoi M; Maruyama W; Akao Y; Zhang J; Parvez H
Toxicology; 2000 Nov; 153(1-3):123-41. PubMed ID: 11090952
[TBL] [Abstract][Full Text] [Related]
13. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies.
Naoi M; Maruyama W; Dostert P; Hashizume Y; Nakahara D; Takahashi T; Ota M
Brain Res; 1996 Feb; 709(2):285-95. PubMed ID: 8833765
[TBL] [Abstract][Full Text] [Related]
14. O-methylation of (+)-(R)- and (-)-(S)-6,7-dihydroxy-1-methyl-1,2,3,4-tetrahydroisoquinoline (salsolinol) in the presence of pig brain catechol-O-methyltransferase.
Hötzl BK; Thomas H
Chirality; 1997; 9(4):367-72. PubMed ID: 9275315
[TBL] [Abstract][Full Text] [Related]
15. Effect of (R)-salsolinol and N-methyl-(R)-salsolinol on the balance impairment between dopamine and acetylcholine in rat brain: involvement in pathogenesis of Parkinson disease.
Zhu W; Wang D; Zheng J; An Y; Wang Q; Zhang W; Jin L; Gao H; Lin L
Clin Chem; 2008 Apr; 54(4):705-12. PubMed ID: 18238832
[TBL] [Abstract][Full Text] [Related]
16. Selective release of serotonin by endogenous alkaloids, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, (R)- and (S)salsolinol, in the rat striatum; in vivo microdialysis study.
Maruyama W; Nakahara D; Dostert P; Hashiguchi H; Ohta S; Hirobe M; Takahashi A; Nagatsu T; Naoi M
Neurosci Lett; 1993 Jan; 149(2):115-8. PubMed ID: 8474680
[TBL] [Abstract][Full Text] [Related]
17. Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin.
Naoi M; Maruyama W; Niwa T; Nagatsu T
J Neural Transm Suppl; 1994; 41():197-205. PubMed ID: 7931227
[TBL] [Abstract][Full Text] [Related]
18. Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine.
Maruyama W; Boulton AA; Davis BA; Dostert P; Naoi M
J Neural Transm (Vienna); 2001; 108(1):11-24. PubMed ID: 11261742
[TBL] [Abstract][Full Text] [Related]
19. N-methyl(R)salsolinol, a dopamine neurotoxin, in Parkinson's disease.
Naoi M; Maruyama W
Adv Neurol; 1999; 80():259-64. PubMed ID: 10410730
[No Abstract] [Full Text] [Related]
20. In vivo formation of salsolinol induced by high acetaldehyde concentration in rat striatum employing microdialysis.
Jamal M; Ameno K; Kubota T; Ameno S; Zhang X; Kumihashi M; Ijiri I
Alcohol Alcohol; 2003; 38(3):197-201. PubMed ID: 12711651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
